Review Article
Circular RNAs in Cardiovascular Disease: An Overview
Table 1
An overview of circular RNAs in various cardiovascular diseases.
| ||||||||||||||||||||||||||||||||||||||||||||||||
a: HRCR can act as miRNA sponges and bind to miR-223. ARC, a kind of protein, is the downstream target of miR-223, so that HRCR can enhance ARC’s protective role as blocking the progression of cardiac pathological hypertrophy and heart failure through inhibiting miR-223 activity. b: Cdr1as can function as miR-7 sponges. SP1 and PARP are miR-7 target genes and can inhibit miR-7-induced protective role during MI development. c: Circ-Foxo3 can hinder transcription factors’ (ID1, E2F1, FAK, and HIF1a) transfer into nucleus so as to repress their antiageing effect. d: CANRIL is an antisense transcript from the INK4/ARF locus resulting from alternative ANRIL transcription and splicing, while cANRIL can also influence the PcG-mediated INK4/ARF silencing. As SNPs on chromosome 9p21 near the INK4/ARF locus can control INK4/ARF expression, which is correlated to atherosclerosis susceptibility, cANRIL can have a regulatory role here. |